Drawing for ABK BIOMEDICAL

USPTO serial 88903680

ABK BIOMEDICAL

Reviewed by CopyMark Law Group

Reg. 7797806Status 700Registered
Filing date
Status date
Registration date
May 20, 2025
Examiner
ELLINGER FATHY, JESSICA M
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ABK BIOMEDICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cynthia A. Moyer

Cynthia A. Moyer FREDRIKSON & BYRON, P.A.60 SOUTH SIXTH STREETSUITE 1500MINNEAPOLIS, MN 55402

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic preparations for medical laboratory use; diagnostic reagents for medical laboratory use; isotopes for medical purposesACTIVE—
009Downloadable electronic medical publications, namely, peer-reviewed articles and newsletters in the field of hypervascular tumor treatmentACTIVE—
010Medical devices, namely, imageable embolic microspheres for intravascular injection for the treatment of tumours and other conditions, namely, arteriovenous malformations; medical devices, namely, imageable embolic microspheres for intravascular injection for in-vivo treatment of tumoursACTIVE—
042Medical research services; computer programming in the medical field; providing medical and scientific research information in the field of pharmaceuticals and clinical trialsACTIVE—
044Providing medical information in the field of hepatic tumors; medical analysis services for the diagnosis of cancer; medical and surgical diagnostic services; medical imaging services; medical services in the field of radiology and nuclear medicineACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 20, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 20, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 1, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 1, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 26, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 10, 2025PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 8, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 1, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 27, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 27, 2025ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Dec 18, 2024RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 16, 2024GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 16, 2024GNSLLETTER OF SUSPENSION E-MAILED—
Jan 16, 2024CNSLSUSPENSION LETTER WRITTEN—
Jan 14, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 14, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 11, 2024ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 10, 2024GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jan 10, 2024GNSIINQUIRY TO SUSPENSION E-MAILED—
Jan 10, 2024CNSISUSPENSION INQUIRY WRITTEN—
Jan 8, 2024RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Aug 7, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 7, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 7, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 4, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 4, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 4, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 4, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 4, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 22, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 22, 2023GNSLLETTER OF SUSPENSION E-MAILED—
May 22, 2023CNSLSUSPENSION LETTER WRITTEN—
May 22, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 22, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 19, 2023ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Mar 7, 2023GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Mar 7, 2023GNSIINQUIRY TO SUSPENSION E-MAILED—
Mar 7, 2023CNSISUSPENSION INQUIRY WRITTEN—
Nov 18, 2022RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 5, 2022GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 5, 2022GNSLLETTER OF SUSPENSION E-MAILED—
Apr 5, 2022CNSLSUSPENSION LETTER WRITTEN—
Apr 4, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 4, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 4, 2022ALIEASSIGNED TO LIE—
Mar 31, 2022ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Oct 19, 2021GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Oct 19, 2021GNSIINQUIRY TO SUSPENSION E-MAILED—
Oct 19, 2021CNSISUSPENSION INQUIRY WRITTEN—
Sep 7, 2021RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 26, 2021GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 26, 2021GNSLLETTER OF SUSPENSION E-MAILED—
Jan 26, 2021CNSLSUSPENSION LETTER WRITTEN—
Jan 25, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 24, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 24, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 9, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 9, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 9, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 31, 2020DOCKASSIGNED TO EXAMINER—
May 19, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 9, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance